KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 113 filers reported holding KRYSTAL BIOTECH INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,854,480 | +9.5% | 179,780 | +10.9% | 0.01% | +20.0% |
| Q2 2023 | $19,038,288 | +48.7% | 162,166 | +1.4% | 0.01% | +25.0% |
| Q1 2023 | $12,800,713 | +0.6% | 159,889 | -0.5% | 0.00% | 0.0% |
| Q4 2022 | $12,723,920 | +16.8% | 160,615 | +2.8% | 0.00% | 0.0% |
| Q3 2022 | $10,893,000 | +11.5% | 156,271 | +5.1% | 0.00% | +33.3% |
| Q2 2022 | $9,768,000 | -1.1% | 148,752 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $9,872,000 | +1.1% | 148,347 | +6.3% | 0.00% | 0.0% |
| Q4 2021 | $9,767,000 | +49.2% | 139,618 | +11.4% | 0.00% | +50.0% |
| Q3 2021 | $6,547,000 | -21.1% | 125,384 | +2.7% | 0.00% | -33.3% |
| Q2 2021 | $8,301,000 | -5.9% | 122,072 | +6.6% | 0.00% | 0.0% |
| Q1 2021 | $8,822,000 | +48.2% | 114,505 | +15.5% | 0.00% | +50.0% |
| Q4 2020 | $5,951,000 | +42.9% | 99,179 | +2.6% | 0.00% | 0.0% |
| Q3 2020 | $4,163,000 | +31.3% | 96,696 | +26.3% | 0.00% | 0.0% |
| Q2 2020 | $3,171,000 | +6.4% | 76,548 | +11.1% | 0.00% | 0.0% |
| Q1 2020 | $2,980,000 | -20.1% | 68,903 | +2.3% | 0.00% | 0.0% |
| Q4 2019 | $3,731,000 | +62.7% | 67,364 | +2.0% | 0.00% | +100.0% |
| Q3 2019 | $2,293,000 | +173.0% | 66,028 | +216.8% | 0.00% | 0.0% |
| Q2 2019 | $840,000 | – | 20,839 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |